Related Experiment Video
Updated: Aug 12, 2026

Cardiac Stress Test Induced by Dobutamine and Monitored by Cardiac Catheterization in Mice
Published on: February 10, 2013
Effects of dobutamine on atrioventricular conduction
Dobutamine, a beta-stimulating catecholamine, significantly improved atrioventricular (A-V) conduction. This study found Dobutamine facilitates A-H intervals without affecting H-V times, suggesting its clinical utility for A-V conduction disturbances.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Atrioventricular (A-V) conduction is critical for cardiac function.
- Understanding the electrophysiological effects of inotropic agents is essential for clinical application.
Purpose of the Study:
- To investigate the effect of Dobutamine on atrioventricular conduction.
- To determine dose-response relationships for A-H and H-V intervals.
Main Methods:
- Bundle of His recordings in six patients under basal and paced conditions.
- Intravenous administration of Dobutamine at 5, 10, and 15 mug/kg/min.
- Analysis of A-H and H-V intervals to assess conduction changes.
Main Results:
- Dobutamine demonstrated dose-dependent facilitation of A-H conduction at 10 and 15 mug/kg/min.
- No significant effect on H-V intervals was observed.
- Heart rate increased only moderately with increasing Dobutamine doses.
Conclusions:
- Dobutamine significantly enhances atrioventricular conduction, specifically the A-H interval.
- The drug does not adversely affect His-ventricular conduction (H-V intervals).
- Dobutamine shows potential as a therapeutic agent for conditions involving A-V conduction disturbances.
More Related Videos
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
09:35Preclinical Cardiac Electrophysiology Assessment by Dual Voltage and Calcium Optical Mapping of Human Organotypic Cardiac Slices
Published on: June 16, 2020
Related Concept Videos
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Heart Failure Drugs: Inotropic Agents
Heart Failure Drugs: β-Blockers
Conduction System of the Heart
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...